In addition, as the major effector of antitumor immunity, CD8+ CTLs eliminate cancer cells by secreting granzyme B (GZB).[20] Thus, we examined CTL activity by measuring GZB release in bone marrow aspirates isolated from healthy donors and myeloma patients before or after treatment. Here, GZMB is linked to plasma cell myeloma.